UNITED GUARDIAN INC
UGNASDAQTrading Snapshot
- Day Range
- $7.11 β $7.28
- 52-Week Range
- $5.58 β $8.45
- Volume
- $3.56B
- Avg Volume
- $3.87B
- Shares Outstanding
- 4.6M
- Next Earnings
- Nov 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $11M
- Last Q Revenue
- $3M
- P/E Ratio
- 13.1
- P/S Ratio
- 2.9x
- EPS (TTM)
- $0.54
- Dividend Yield
- 7.76%
- Dilution (1yr)
- +0.0%
Why Investors Own UG
- βHigh-growth profile β revenue up +45.1% YoY with expanding US Equity exposure.
- βHealthy economics β 44% gross margin and 22% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
UNITED GUARDIAN INC
UGAbout UNITED GUARDIAN INC
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Upside Gold Announces September Investor Outreach Schedule
CALGARY, Alberta β TheNewswire - September 16, 2026Β β Upside Gold Corp. (βUpsideβ or the βCompanyβ) (CSE: UG) (FSE: 47I) (OTCQB: UGODF)Β is pleased to announce its September investor outreach schedule, including participa

UG Q2 Earnings Rise Y/Y on Strong Cosmetic Ingredient Sales
United-Guardian's cosmetic ingredient growth supports higher Q2 sales and earnings per share, while other income also strengthens the results.

United-Guardian Reports Second Quarter Results
HAUPPAUGE, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2026. Second quarter net sales increased by 10% from $2,

United-Guardian Declares Cash Dividend
HAUPPAUGE, N.Y., July 16, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on July 14, 2026, declared a cash dividend of $0.30 per share, to

UG Outperforms Industry in 6 Months: Buy, Sell or Hold the Stock?
United-Guardian's rally reflects stronger sales, distribution expansion and recovering cosmetic demand, but valuation and trade risks may limit its near-term appeal.